Sanofi’s chief executive Olivier Brandicourt said the acquisition “enhances its presence in specialty care and leadership in rare diseases…and creates a platform for growth in other rare blood disorders.” Bioverativ has latest-generation treatments for hemophilia, a disorder where blood does not clot properly to stop bleeding.The deal “looks logical, but expensive”, with only modest potential to drive growth in the medium term, judged analysts at the Jefferies firm.
You can now access a live camera feed from your desktop using an internet browser.
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70 titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media.
George, there's more to life than having 365 days of boring sunshine a year.
Thankfully, she is on the mend and getting better each day.
- Registered at This domain is registered at Namecheap This domain was recently registered at Namecheap. This domain is registered at Namecheap This domain was recently registered at Namecheap.